FC24: Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity
Released on
December 12, 2024
Duration
45 minutes
Earn up to
0.75 AMA PRA Category 1 Credit
Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity
This activity is supported by educational grants from Genentech, a member of the Roche Group, Novartis Pharmaceuticals Corporation, and Sanofi and Regeneron Pharmaceuticals, Inc.